National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 3 of 3 Research Studies DisplayedCotter JM, Tyler A, Reese J
Steroid variability in pediatric inpatient asthmatics: survey on provider preferences of dexamethasone versus prednisone.
This study looked at pediatric emergency department (ED) inpatient use of dexamethasone versus prednisone by providers for asthma treatment. A survey was distributed to providers who care for inpatient asthmatics. Ninety-two providers completed the survey. When patients received dexamethasone in the ED, 44% continued dexamethasone, 14% switched to prednisone, 2% stopped steroid use, and 40% said it depended on the circumstances. Hospitalists were significantly more likely to continue dexamethasone than pulmonologists (61% versus 15%). Switching to prednisone included factors such as severity of exacerbation (73%) and asthma history (47%). Just over half of providers (5f1%) felt uncomfortable using dexamethasone because of “minimal data to support [its] use inpatient.”
AHRQ-funded; HS026512.
Citation: Cotter JM, Tyler A, Reese J .
Steroid variability in pediatric inpatient asthmatics: survey on provider preferences of dexamethasone versus prednisone.
J Asthma 2020 Sep;57(9):942-48. doi: 10.1080/02770903.2019.1622713..
Keywords: Children/Adolescents, Asthma, Respiratory Conditions, Medication, Inpatient Care, Care Management, Hospitalization, Emergency Department, Practice Patterns, Provider: Physician, Provider
Olfson M
Surveillance of adverse psychiatric medication events.
This article estimates the numbers and rates of adverse drug event (ADE) emergency department (ED) visits involving psychiatric medications among US adults between January 1, 2009, and December 31, 2011. The author finds that there were an estimated 89,094 psychiatric medication ADE emergency department visits annually, with 19.3 percent resulting in hospitalization and 49.4 percent involving patients aged 19 to 44.
AHRQ-funded; HS021112.
Citation: Olfson M .
Surveillance of adverse psychiatric medication events.
JAMA 2015 Mar 24-31;313(12):1256-7. doi: 10.1001/jama.2014.15743..
Keywords: Emergency Department, Behavioral Health, Hospitalization, Medication
Morrato EH, Parks J, Campagna EJ
Comparative effectiveness of injectable paliperidone palmitate versus oral atypical antipsychotics: early postmarketing evidence.
The researchers compared the likelihood of hospitalization and emergency department visits in Medicaid patients from the state of Missouri starting paliperidone palmitate versus oral atypical (also known as second-generation) antipsychotics. They found that paliperidone palmitate treatment resulted in a statistically significant 37 percent reduction in the adjusted likelihood of an all-cause emergency department visit. There was no statistically significant reduction in hospitalization.
AHRQ-funded; HS019464.
Citation: Morrato EH, Parks J, Campagna EJ .
Comparative effectiveness of injectable paliperidone palmitate versus oral atypical antipsychotics: early postmarketing evidence.
J Comp Eff Res 2015 Mar-Apr;4(2):89-99. doi: 10.2217/cer.14.50..
Keywords: Medication, Hospitalization, Behavioral Health, Emergency Department, Healthcare Utilization